List of Tables
Table 1. Newcastle Disease Vaccine Market Trends
Table 2. Newcastle Disease Vaccine Market Drivers & Opportunity
Table 3. Newcastle Disease Vaccine Market Challenges
Table 4. Newcastle Disease Vaccine Market Restraints
Table 5. Global Newcastle Disease Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Newcastle Disease Vaccine Revenue Market Share by Company (2020-2025)
Table 7. Global Newcastle Disease Vaccine Sales Volume by Company (2020-2025) & (M Doses)
Table 8. Global Newcastle Disease Vaccine Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Newcastle Disease Vaccine Price by Company (2020-2025) & (USD/K Doses)
Table 10. Key Manufacturers Newcastle Disease Vaccine Manufacturing Base and Headquarters
Table 11. Key Manufacturers Newcastle Disease Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Newcastle Disease Vaccine
Table 13. Global Newcastle Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Newcastle Disease Vaccine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Newcastle Disease Vaccine Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Newcastle Disease Vaccine Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Newcastle Disease Vaccine Sales Market Share in Value by Type (2020-2025)
Table 20. Global Newcastle Disease Vaccine Sales Market Share in Value by Type (2026-2031)
Table 21. Global Newcastle Disease Vaccine Sales Volume by Type: 2020 VS 2024 VS 2031 (M Doses)
Table 22. Global Newcastle Disease Vaccine Sales Volume by Type (2020-2025) & (M Doses)
Table 23. Global Newcastle Disease Vaccine Sales Volume by Type (2026-2031) & (M Doses)
Table 24. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Newcastle Disease Vaccine Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Newcastle Disease Vaccine Price by Type (2020-2025) & (USD/K Doses)
Table 27. Global Newcastle Disease Vaccine Price by Type (2026-2031) & (USD/K Doses)
Table 28. Global Newcastle Disease Vaccine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Newcastle Disease Vaccine Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Newcastle Disease Vaccine Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2020-2025)
Table 32. Global Newcastle Disease Vaccine Sales Market Share in Value by Application (2026-2031)
Table 33. Global Newcastle Disease Vaccine Sales Volume by Application: 2020 VS 2024 VS 2031 (M Doses)
Table 34. Global Newcastle Disease Vaccine Sales Volume by Application (2020-2025) & (M Doses)
Table 35. Global Newcastle Disease Vaccine Sales Volume by Application (2026-2031) & (M Doses)
Table 36. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Newcastle Disease Vaccine Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Newcastle Disease Vaccine Price by Application (2020-2025) & (USD/K Doses)
Table 39. Global Newcastle Disease Vaccine Price by Application (2026-2031) & (USD/K Doses)
Table 40. Global Newcastle Disease Vaccine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Newcastle Disease Vaccine Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Newcastle Disease Vaccine Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Newcastle Disease Vaccine Sales Value by Region (2020-2025) & (%)
Table 44. Global Newcastle Disease Vaccine Sales Value by Region (2026-2031) & (%)
Table 45. Global Newcastle Disease Vaccine Sales Volume by Region (M Doses): 2020 VS 2024 VS 2031
Table 46. Global Newcastle Disease Vaccine Sales Volume by Region (2020-2025) & (M Doses)
Table 47. Global Newcastle Disease Vaccine Sales Volume by Region (2026-2031) & (M Doses)
Table 48. Global Newcastle Disease Vaccine Sales Volume by Region (2020-2025) & (%)
Table 49. Global Newcastle Disease Vaccine Sales Volume by Region (2026-2031) & (%)
Table 50. Global Newcastle Disease Vaccine Average Price by Region (2020-2025) & (USD/K Doses)
Table 51. Global Newcastle Disease Vaccine Average Price by Region (2026-2031) & (USD/K Doses)
Table 52. Key Countries/Regions Newcastle Disease Vaccine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Newcastle Disease Vaccine Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Newcastle Disease Vaccine Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Newcastle Disease Vaccine Sales Volume, (2020-2025) & (M Doses)
Table 56. Key Countries/Regions Newcastle Disease Vaccine Sales Volume, (2026-2031) & (M Doses)
Table 57. Merial Company Information
Table 58. Merial Introduction and Business Overview
Table 59. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 60. Merial Newcastle Disease Vaccine Product Offerings
Table 61. Merial Recent Development
Table 62. CEVA Company Information
Table 63. CEVA Introduction and Business Overview
Table 64. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 65. CEVA Newcastle Disease Vaccine Product Offerings
Table 66. CEVA Recent Development
Table 67. QYH Biotech Company Information
Table 68. QYH Biotech Introduction and Business Overview
Table 69. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 70. QYH Biotech Newcastle Disease Vaccine Product Offerings
Table 71. QYH Biotech Recent Development
Table 72. Ringpu Biology Company Information
Table 73. Ringpu Biology Introduction and Business Overview
Table 74. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 75. Ringpu Biology Newcastle Disease Vaccine Product Offerings
Table 76. Ringpu Biology Recent Development
Table 77. Yebio Company Information
Table 78. Yebio Introduction and Business Overview
Table 79. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Yebio Newcastle Disease Vaccine Product Offerings
Table 81. Yebio Recent Development
Table 82. Harbin Veterinary Research Institute Company Information
Table 83. Harbin Veterinary Research Institute Introduction and Business Overview
Table 84. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 85. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Offerings
Table 86. Harbin Veterinary Research Institute Recent Development
Table 87. Merck Animal Health Company Information
Table 88. Merck Animal Health Introduction and Business Overview
Table 89. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 90. Merck Animal Health Newcastle Disease Vaccine Product Offerings
Table 91. Merck Animal Health Recent Development
Table 92. DHN Company Information
Table 93. DHN Introduction and Business Overview
Table 94. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 95. DHN Newcastle Disease Vaccine Product Offerings
Table 96. DHN Recent Development
Table 97. Zoetis Company Information
Table 98. Zoetis Introduction and Business Overview
Table 99. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 100. Zoetis Newcastle Disease Vaccine Product Offerings
Table 101. Zoetis Recent Development
Table 102. ChengDu Tecbond Company Information
Table 103. ChengDu Tecbond Introduction and Business Overview
Table 104. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 105. ChengDu Tecbond Newcastle Disease Vaccine Product Offerings
Table 106. ChengDu Tecbond Recent Development
Table 107. Elanco (Lohmann) Company Information
Table 108. Elanco (Lohmann) Introduction and Business Overview
Table 109. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 110. Elanco (Lohmann) Newcastle Disease Vaccine Product Offerings
Table 111. Elanco (Lohmann) Recent Development
Table 112. FATRO Company Information
Table 113. FATRO Introduction and Business Overview
Table 114. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 115. FATRO Newcastle Disease Vaccine Product Offerings
Table 116. FATRO Recent Development
Table 117. CAVAC Company Information
Table 118. CAVAC Introduction and Business Overview
Table 119. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. CAVAC Newcastle Disease Vaccine Product Offerings
Table 121. CAVAC Recent Development
Table 122. Vaksindo Company Information
Table 123. Vaksindo Introduction and Business Overview
Table 124. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 125. Vaksindo Newcastle Disease Vaccine Product Offerings
Table 126. Vaksindo Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Newcastle Disease Vaccine Downstream Customers
Table 130. Newcastle Disease Vaccine Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Newcastle Disease Vaccine Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Newcastle Disease Vaccine Sales Volume (2020-2031) & (M Doses)
Figure 5. Global Newcastle Disease Vaccine Sales Price (2020-2031) & (USD/K Doses)
Figure 6. Newcastle Disease Vaccine Report Years Considered
Figure 7. Global Newcastle Disease Vaccine Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Newcastle Disease Vaccine Players Sales Volume Ranking (2024) & (M Doses)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Newcastle Disease Vaccine Revenue in 2024
Figure 10. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Live Vaccines Picture
Figure 12. Killed Vaccines Picture
Figure 13. Global Newcastle Disease Vaccine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Newcastle Disease Vaccine Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Newcastle Disease Vaccine Sales Volume by Type (2020 VS 2024 VS 2031) & (M Doses)
Figure 16. Global Newcastle Disease Vaccine Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Newcastle Disease Vaccine Price by Type (2020-2031) & (USD/K Doses)
Figure 18. Product Picture of Chicken
Figure 19. Product Picture of Duck & Goose
Figure 20. Product Picture of Other
Figure 21. Global Newcastle Disease Vaccine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Newcastle Disease Vaccine Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Newcastle Disease Vaccine Sales Volume by Application (2020 VS 2024 VS 2031) & (M Doses)
Figure 24. Global Newcastle Disease Vaccine Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Newcastle Disease Vaccine Price by Application (2020-2031) & (USD/K Doses)
Figure 26. North America Newcastle Disease Vaccine Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Newcastle Disease Vaccine Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Newcastle Disease Vaccine Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Newcastle Disease Vaccine Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Newcastle Disease Vaccine Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Newcastle Disease Vaccine Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Newcastle Disease Vaccine Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Newcastle Disease Vaccine Sales Volume (%), (2020-2031)
Figure 38. United States Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Newcastle Disease Vaccine Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Newcastle Disease Vaccine Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Newcastle Disease Vaccine Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Newcastle Disease Vaccine Sales Value by Application (%), 2024 VS 2031
Figure 44. China Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Newcastle Disease Vaccine Sales Value by Type (%), 2024 VS 2031
Figure 46. China Newcastle Disease Vaccine Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Newcastle Disease Vaccine Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Newcastle Disease Vaccine Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Newcastle Disease Vaccine Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Newcastle Disease Vaccine Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Newcastle Disease Vaccine Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Newcastle Disease Vaccine Sales Value by Application (%), 2024 VS 2031
Figure 56. India Newcastle Disease Vaccine Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Newcastle Disease Vaccine Sales Value by Type (%), 2024 VS 2031
Figure 58. India Newcastle Disease Vaccine Sales Value by Application (%), 2024 VS 2031
Figure 59. Newcastle Disease Vaccine Industrial Chain
Figure 60. Newcastle Disease Vaccine Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
